[HTML][HTML] Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis

L Tretter, A Patocs, C Chinopoulos - Biochimica et Biophysica Acta (BBA) …, 2016 - Elsevier
Succinate is an important metabolite at the cross-road of several metabolic pathways, also
involved in the formation and elimination of reactive oxygen species. However, it is …

[HTML][HTML] Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms

M Jakaria, S Azam, ME Haque, SH Jo, MS Uddin… - Redox biology, 2019 - Elsevier
Taurine is a sulfur-containing amino acid and known as semi-essential in mammals and is
produced chiefly by the liver and kidney. It presents in different organs, including retina …

Most reported genetic associations with general intelligence are probably false positives

CF Chabris, BM Hebert, DJ Benjamin… - Psychological …, 2012 - journals.sagepub.com
General intelligence (g) and virtually all other behavioral traits are heritable. Associations
between g and specific single-nucleotide polymorphisms (SNPs) in several candidate genes …

Inborn errors of metabolism

CR Ferreira, CDM van Karnebeek - Handbook of clinical neurology, 2019 - Elsevier
Inborn errors of metabolism, also known as inherited metabolic diseases, constitute an
important group of conditions presenting with neurologic signs in newborns. They are …

γ-Hydroxybutyric acid: pharmacokinetics, pharmacodynamics, and toxicology

MA Felmlee, BL Morse, ME Morris - The AAPS journal, 2021 - Springer
Gamma-hydroxybutyrate (GHB) is a short-chain fatty acid present endogenously in the brain
and used therapeutically for the treatment of narcolepsy, as sodium oxybate, and for alcohol …

The presence and severity of epilepsy coincide with reduced γ‐aminobutyrate and cortical excitatory markers in succinic semialdehyde dehydrogenase deficiency

I Tokatly Latzer, M Bertoldi, ML DiBacco, E Arning… - …, 2023 - Wiley Online Library
Objective Succinic semialdehyde dehydrogenase deficiency (SSADHD) is a rare inherited
metabolic disorder caused by a defect of γ‐aminobutyrate (GABA) catabolism. Despite the …

Neuropathological mechanisms of seizures in autism spectrum disorder

RE Frye, MF Casanova, SH Fatemi… - Frontiers in …, 2016 - frontiersin.org
This manuscript reviews biological abnormalities shared by autism spectrum disorder (ASD)
and epilepsy. Two neuropathological findings are shared by ASD and epilepsy …

SDHAF4 promotes mitochondrial succinate dehydrogenase activity and prevents neurodegeneration

JG Van Vranken, DK Bricker, N Dephoure, SP Gygi… - Cell metabolism, 2014 - cell.com
Succinate dehydrogenase (SDH) occupies a central place in cellular energy production,
linking the tricarboxylic cycle with the electron transport chain. As a result, a subset of …

A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel

RE Frye, D Rossignol, MF Casanova… - Frontiers in public …, 2013 - frontiersin.org
Despite the fact that seizures are commonly associated with autism spectrum disorder
(ASD), the effectiveness of treatments for seizures has not been well studied in individuals …

Succinic semialdehyde dehydrogenase deficiency (SSADHD): Pathophysiological complexity and multifactorial trait associations in a rare monogenic disorder of …

P Malaspina, JB Roullet, PL Pearl, GR Ainslie… - Neurochemistry …, 2016 - Elsevier
Discovered some 35 years ago, succinic semialdehyde dehydrogenase deficiency
(SSADHD) represents a rare, autosomal recessively-inherited defect in the second step of …